Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rajeev Masson

Surgery Springfield, MO Medical Doctor

NPI 1619322039 CMS profile 9273780

1229 E Seminole St Ste 520, Springfield, MO 65804

Open in the dashboard

General payments

$5,242

32 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rajeev Masson of Springfield, MO is reported in the CMS Open Payments database as having received $5,242 across 32 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,227 13
2024 General $2,036 8
2023 General $111 3
2022 General $1,818 5
2021 General $50 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rajeev Masson
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Rajeev Masson were reported at $1,227. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Rajeev Masson Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $50 $168 $50–$904 $132
2022 $1,818 $224 $76–$1,218 $149
2023 $111 $253 $82–$1,255 $160
2024 $2,036 $279 $90–$1,381 $164
2025 $1,227 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $1,887 5 payments
  2. AxoGen $1,840 6 payments
  3. DePuy Synthes Sales Inc. $422 6 payments
  4. Medtronic, Inc. $357 2 payments
  5. Ethicon US, LLC $144 1 payment
  6. Bolton Medical Inc $119 1 payment
  7. Stryker Corporation $93 1 payment
  8. Integra LifeSciences Corporation $91 1 payment
  9. Abbott Laboratories $83 1 payment
  10. Smith+Nephew, Inc. $79 1 payment
  11. Other $127 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $2,339 5 payments
  2. Food and Beverage $1,904 26 payments
  3. Education $1,000 1 payment
Products named General payments · program years 2021–2025
  1. Avance Nerve Graft $1,759 4 payments
  2. AxoGuard Nerve Connector $1,759 4 payments
  3. AXOGUARD NERVE PROTECTOR $1,759 4 payments
  4. Axoguard HA+ Nerve Protector $1,759 4 payments
  5. AXOGUARD NERVE CAP $1,759 4 payments
  6. DAVINCI XI $1,000 1 payment
  7. Da Vinci Surgical System $887 4 payments
  8. ADVISA DR MRI SURESCAN $284 1 payment
  9. TRUMATCH $174 2 payments
  10. VISTASEAL $144 1 payment
  11. Other $1,712 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

198

Median for Otolaryngology: 297

Drug cost

$1,109

Median for Otolaryngology: $6,314

Branded share of claims

0%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 139 $594
Nystatin Generic 16 $291
Pantoprazole Sodium Generic 11 $93
Levothyroxine Sodium Generic 21 $66
Calcitriol Generic 11 $65

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$82,539

Medicare's payments for the services billed

Medicare patients

113

Average age 70

Services billed

286

55 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 55%
Diabetes 39%
Ischemic heart disease 35%
Chronic kidney disease 29%
Depression 29%
COPD 26%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

32 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record